These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11991532)

  • 21. Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine using solid-phase microextraction, direct on-fiber derivatization, and analysis by GC-MS.
    Jurado C; Giménez MP; Soriano T; Menéndez M; Repetto M
    J Anal Toxicol; 2000; 24(1):11-6. PubMed ID: 10654563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by solid-phase extraction and GC-MS: a method optimized for high-volume laboratories.
    Stout PR; Horn CK; Klette KL
    J Anal Toxicol; 2002; 26(5):253-61. PubMed ID: 12166811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.
    de Boer D; Tan LP; Gorter P; van de Wal RM; Kettenes-van den Bosch JJ; de Bruijn EA; Maes RA
    J Mass Spectrom; 1997 Nov; 32(11):1236-46. PubMed ID: 9373962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed-mode solid-phase extraction procedures for the determination of MDMA and metabolites in urine using LC-MS, LC-UV, or GC-NPD.
    Jenkins KM; Young MS; Mallet CR; Elian AA
    J Anal Toxicol; 2004; 28(1):50-8. PubMed ID: 14987425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enantiomeric separation and quantitation of (+/-)-amphetamine, (+/-)-methamphetamine, (+/-)-MDA, (+/-)-MDMA, and (+/-)-MDEA in urine specimens by GC-EI-MS after derivatization with (R)-(-)- or (S)-(+)-alpha-methoxy-alpha-(trifluoromethy)phenylacetyl chloride (MTPA).
    Paul BD; Jemionek J; Lesser D; Jacobs A; Searles DA
    J Anal Toxicol; 2004 Sep; 28(6):449-55. PubMed ID: 15516295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.
    Pizarro N; de la Torre R; Farré M; Segura J; Llebaria A; Joglar J
    Bioorg Med Chem; 2002 Apr; 10(4):1085-92. PubMed ID: 11836119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.
    Pirnay SO; Abraham TT; Lowe RH; Huestis MA
    J Anal Toxicol; 2006 Oct; 30(8):563-9. PubMed ID: 17132253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.
    Fallon JK; Kicman AT; Henry JA; Milligan PJ; Cowan DA; Hutt AJ
    Clin Chem; 1999 Jul; 45(7):1058-69. PubMed ID: 10388483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage.
    Mueller M; Peters FT; Huestis MA; Ricaurte GA; Maurer HH
    Forensic Sci Int; 2009 Jan; 184(1-3):64-8. PubMed ID: 19131196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of multiple internal standards: deuterated analogues of methylenedioxymethamphetamine, methylenedioxyamphetamine, methamphetamine, and amphetamine.
    Lin DL; Liu HC; Yin RM; Chen DT; Soong SJ; Liu RH
    J Anal Toxicol; 2004; 28(8):650-4. PubMed ID: 15538959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
    Sprega G; Kobidze G; Lo Faro AF; Pichini S; Farkas T; Tini A; Mskhiladze A; Busardò FP; Chankvetadze B
    J Pharm Biomed Anal; 2024 Jun; 243():116076. PubMed ID: 38430614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.
    Peters FT; Samyn N; Lamers CT; Riedel WJ; Kraemer T; de Boeck G; Maurer HH
    Clin Chem; 2005 Oct; 51(10):1811-22. PubMed ID: 16099938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
    Matsushima K; Nagai T; Kamiyama S
    J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening.
    Huang Z; Zhang S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):241-7. PubMed ID: 12860031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDA-MDMA concentrations in urine specimens.
    Kunsman GW; Levine B; Kuhlman JJ; Jones RL; Hughes RO; Fujiyama CI; Smith ML
    J Anal Toxicol; 1996; 20(7):517-21. PubMed ID: 8934299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.
    Peters FT; Samyn N; Wahl M; Kraemer T; De Boeck G; Maurer HH
    J Anal Toxicol; 2003; 27(8):552-9. PubMed ID: 14670133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine.
    Stout PR; Klette KL; Wiegand R
    J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecularly imprinted-solid phase extraction combined with simultaneous derivatization and dispersive liquid-liquid microextraction for selective extraction and preconcentration of methamphetamine and ecstasy from urine samples followed by gas chromatography.
    Djozan D; Farajzadeh MA; Sorouraddin SM; Baheri T
    J Chromatogr A; 2012 Jul; 1248():24-31. PubMed ID: 22704883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
    Shima N; Katagi M; Kamata H; Zaitsu K; Kamata T; Nishikawa M; Miki A; Tsuchihashi H; Sakuma T; Nemoto N
    Xenobiotica; 2008 Mar; 38(3):314-24. PubMed ID: 18274959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselective method development and validation for determination of concentrations of amphetamine-type stimulants and metabolites in human urine using a simultaneous extraction-chiral derivatization approach.
    Wan Raihana WA; Gan SH; Tan SC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):8-16. PubMed ID: 21147046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.